Acurx pharmaceuticals to discuss fourth quarter and full year 2022 financial results and provide business update

Staten island, n.y. , march 6, 2023 /prnewswire/ -- acurx pharmaceuticals, inc. (nasdaq: acxp) ("acurx" or the "company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the company will discuss its fourth quarter 2022 and fiscal year end 2022 financial results on thursday, march 16, 2022, at 8:00 am et before the u.s. financial markets open.
ACXP Ratings Summary
ACXP Quant Ranking